Lactobacillus Rhamnosus and PCOS Treatment

Last updated: April 19, 2022
Sponsor: Poznan University of Life Sciences
Overall Status: Completed

Phase

N/A

Condition

Obesity

Diabetes (Pediatric)

Stress

Treatment

N/A

Clinical Study ID

NCT03902301
Project PCOS
  • Ages 18-40
  • Female

Study Summary

The effect of Lactobacillus rhamnosus supplementation on body weight, hyperandrogenism and insulin resistance in overweight and obesity women with Polycystic Ovary Syndrome will be analysed.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • patients diagnosed with PCOS,

  • BMI> 28 kg/m2 (overweight or obesity),

  • patients not participating in other similar research programs at the same time,

  • no previous operations on ovaries such as: laparoscopy, ovarian cautery etc.,

  • written agreement to take part in the research.

Exlusion criteria:

  • the use of antibiotics or probiotics within 6 months before the start of the experiment,

  • the use of pharmacological agents or hormones that may affect the course of the menstrual cycle or metabolic rate within 3 months,

  • the use of medicament that may affect on carbohydrate metabolism within 4 weeks,

  • failure to comply with dietary recommendations established during the nutritional intervention,

  • the use of weight loss supplements during the study,

  • clinical diagnosis of digestive disease (for example: irritable bowel syndrome, ulcerative colitis, Crohn's disease, celiac disease),

  • pregnancy and breast feeding.

Study Design

Total Participants: 80
Study Start date:
April 01, 2018
Estimated Completion Date:
December 31, 2020

Connect with a study center

  • Poznan University of Life Sciences

    Poznan, 60-624
    Poland

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.